Diligent Pharma Employees Named 2025 Innovate100 Award Recipients

We are proud to announce that our Chief Technology Officer, Christopher Sallemi, and Product Manager, Jackson Miller, have been recognized as 2025 Innovation+ Innovate100 award recipients. This recognition celebrates leaders across New Jersey who are driving meaningful progress in their industries.

This achievement reflects more than individual accomplishment. It is a reflection of the broader mission our entire team at Diligent Pharma is proud to champion. As noted by Christopher Sallemi,

"Innovation means harnessing cutting-edge cloud services and AI technologies to create solutions that drive meaningful, transformative change in our industry and beyond"

At Diligent Pharma, that transformation is well underway. Our new platform, Diligent360, modernizes how clinical trial Sponsors and Vendors manage compliance, risk, and qualification, improving compliance and reducing redundancies through centralized, data-driven systems.

Chris and Jackson's recognition underscores the innovation happening across our organization as we work to advance clinical trial execution.